BrachyBytes

In This Issue

Hypofractionation & BCT

SAVI Research Published in Red Journal

Introducing SAVI Sisters!

BrachyBytes Editorial Advisory Board

Robert Kuske, M.D.


Coral Quiet, M.D
Jay Reiff, Ph.D.
Dan Scanderbeg, Ph.D.
John Sweet, M.S.

Catheryn Yashar, M.D.


Vic Zannis, M.D.


Upcoming Events

2010 Breast Cancer Symposium
October 1-3, 2010
Gaylord National Hotel
Washington, D.C.

American Society for Radiation Oncology
Oct 31-Nov 1, 2010
San Diego, CA

 

Follow-up Links

Past Issues
Cianna Medical
SAVI Sisters
Virginia Hospital Center
Red Journal
UCSD Moores Cancer Center
ASTRO

September 2010

Hypofractionation & Breast Conservation Therapy
Nadim Nasr, MD

On August 4, the
American Society of Radiation Oncology (ASTRO) published evidence-based guidelines for the use of hypofractionated whole breast irradiation (WBI). As a
result, U.S. cancer centers now have an official position from ASTRO regarding
the treatment protocols that have been in use for years in Canada, the United
Kingdom and Australia.However, some
controversy remains regarding the suitability of the accelerated treatment
schedule, particularly given what many view as insufficient follow-up on
long-term complications.
Nadim Nasr, MD
Radiation oncologist Nadim Nasr, M.D. of Virginia Hospital Center discusses his
views on the guidelines and the potential impact hypofractionation will have on
the breast cancer treatment paradigm. Read More

What are your thoughts on the use of hypofractionated whole breast irradiation?
Email us to share your opinion!

 

 

SAVI Data Published in the Red Journal

A new study at the Moores UCSD Cancer Center and Arizona Oncology Services shows that after almost two years, the radiation delivered with SAVI controls the rate of cancer and may reduce complications seen with alternate types of brachytherapy. The study also demonstrates the accuracy and flexibility of the device to maximize the dose to the target tissue and minimize the exposure of healthy surrounding tissue and organs. Read more from UCSD

“This is the first paper that documents the patients’ status after almost two years,” said Catheryn Yashar, MD, one of the study’s lead authors. “After almost two years, the patients showed that the treatment was well-tolerated without experiencing significant side effects. To date, the control rate of cancer is also very promising.

Read about the study in Diagnostic Imaging, Health Imaging and Aunt Minnie.

SAVI Sisters Raises Awareness About 5-Day Radiation 

We are pleased to announce
the launch of
SAVI Sisters™, a new program that will assist you in
providing education and support for your patients, create a community of people
dedicated to spreading the word about breast cancer treatment options and give
women a place to find others who share common experiences. Read more

Everyone is invited to
become a SAVI Sister – SAVI Sisterswomen who have been treated with SAVI®, people who have
supported a loved one through their journey with breast cancer, as well as
physicians and healthcare providers. A SAVI Sister is one who is committed to
sharing stories of what they have learned through treatment, or simply
committed to spreading the word about the choices women have when it comes to
breast cancer treatment.

Visit www.savisisters.com for more information or contact us to receive your complimentary SAVI Sisters lapel pins.